Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2026 Feb 9;6(2):e0005932. doi: 10.1371/journal.pgph.0005932

Impact of early pregnancy body mass index and gestational weight gain on birth outcomes: Findings from a pregnancy cohort in South Delhi, India

Saijuddin Shaikh 1,#, Ranadip Chowdhury 1,*,#, Neeta Dhabhai 1,, Sunita Taneja 1,#, Nita Bhandari 1,#
Editor: Nicola Hawley2
PMCID: PMC12885321  PMID: 41662334

Abstract

Early pregnancy low body mass index (BMI) and inadequate gestational weight gain (IGWG) are significant risk factors for adverse birth outcomes. However, the specific risks among underweight women with IGWG or excessive GWG (EGWG), as well as overweight/obese women with IGWG or EGWG, compared to normal BMI women with adequate GWG (AGWG), remain poorly defined.The primary objective is to estimate the risk of small for gestational age (SGA) among women with underweight at early pregnancy and IGWG compared to women with normal weight at early pregnancy and AGWG. Data were derived from a randomized factorial trial. BMI was assessed at <14 weeks of gestation, and women weight was measured monthly until 32 weeks, biweekly until 36 weeks and weekly until delivery. GWG was classified as per Institute of Medicine (IOM) guidelines. Infant weight and length were measured <14 days of birth. Regression analysis assessed associations (risk ratio, RR) between BMI, GWG, and birth outcomes. The highest prevalence of SGA (62.4%; 95%CI 57.1–67.5) was observed among underweight women with IGWG. Normal BMI women with IGWG (aRR 1.36; 95%CI 1.21–1.53) and underweight women with IGWG (aRR 1.65; 95%CI 1.44–1.89) increased, and overweight/obese women with excessive GWG (EGWG) reduced risk of SGA (aRR 0.56; 95%CI 0.43–0.72), compared to normal BMI women with AGWG. IGWG among normal women (aRR 1.43; 95%CI 1.21–1.70) and IGWG among underweight women (aRR 2·09; 95%CI 1·74–2·52) also increased, and overweight/obese women with EGWG (aRR 0.73; 95%CI 0.54–0.98) reduced the risk of low birth weight (LBW). Underweight women with IGWG face the highest risk of adverse outcomes, while EGWG among overweight or obese women reduces the risk of adverse outcomes. Monitoring of GWG alongside early pregnancy BMI is essential for guiding targeted nutritional intervention to improve pregnancy outcomes.

Introduction

Small and vulnerable newborns are significant public health challenges. Term SGA babies are heavily concentrated in South Asia, accounting for nearly two-thirds (63%) of the global burden [1]. Additionally, South Asia has the highest prevalence of preterm birth at 13.2% [1,2]. In India, the prevalence of preterm, term SGA, LBW and stunting are comparatively higher than other low and middle income countries (LMICs) [3,4]. These vulnerable babies are associated with higher risks of morbidity, mortality and growth faltering during infancy and childhood, poor cognitive performance, and developmental delays compared to their healthy peers. These children are also decreased opportunities in education and employment, and a higher likelihood of non-communicable diseases later in life compared to normal infants [58].

Gestational weight gain (GWG) plays a pivotal role in determining pregnancy outcomes and long-term health trajectories for both mother and child [9]. Inadequate GWG is a well-established risk factor for adverse outcomes, including LBW, SGA infants, and preterm birth [10,11]. On the other hand, excessive GWG has been associated with higher risk of cesarean section, large for gestational age, macrosomia, maternal weight retention and obesity in the offspring later in life [1113]. Prepregnancy nutritional status is another vital determinant risk factor of birth outcomes. Evidence suggested that lower prepregnancy BMI is associated with preterm birth, while higher BMI is linked to large for gestational age and macrosomia [14,15]. However, the combined effect of early pregnancy BMI and trimester-specific GWG on birth outcomes in LMICs is scared. A study in India has found the higher risk of adverse birth outcomes among women whom GWG was lower than the IOM guidelines compared to those who had within the IOM guidelines [16]. That study did not mention the effect of total and trimester-specific GWG for underweight or overweight/obese women on adverse birth outcomes. The US Institute of Medicine guidelines 2009 provide recommendations for GWG based on prepregnancy BMI [17], however, there is a lack of GWG guidelines designed to be relevant to populations in LMICs. Therefore, the extent to which these risks vary across BMI and GWG categories, particularly in South Asia, remains unclear.

India is the country where underweight and overweight are the public health concern, and it is important to clarify the combined effect of early pregnancy BMI and trimester-specific GWG on the risk of adverse birth outcomes. We hypothesize that early pregnancy underweight (BMI < 18.5 kg/m2) women with inadequate gestational weight gain increase the risk of small for gestational age babies, compared to normal body mass index women with adequate gestational weight gain. We also aimed to explore the association of gestational weight gain and early pregnancy body mass index with low birth weight, preterm, stunting and wasting.

Materials and methods

Ethics statement

The Ethics Review Committee of the Society for Applied Studies, New Delhi (SAS/ ERC/LG/2027), Vardhman Medical College, Safdarjung Hospital, New Delhi (IEC/SJH/VMMC/PROJECT-2017/694) and the World Health Organization, Geneva (ERC.0002934) have approved the study. The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. The trial was registered with the Clinical Trials Registry of India (CTRI/2017/06/008908). Written informed consent was obtained from all mothers prior to participation. All data were collected in a private area of the participants’ homes, and confidentiality of the collected data was maintained.

Study design and data source

This analysis used data from Women and Infants Integrated Intervention for Growth Study (WINGS), an unmasked factorial individually randomized controlled trial conducted in urban and peri-urban low-to-middle income communities in South Delhi, India. Details about the main trial (WINGS) have been published elsewhere [2]. Prepregnant women were enrolled from 1 July 2017–30 December 2019 and were followed for the period of 18 months, from 01 January 2020–30 June 2021.

Briefly, a household survey was conducted to identify eligible married women between 18–30 years of age, living with husband, and staying permanently in the study area. After a written informed consent (first consent), height (Seca-213 stadiometer) and weight (Salter 9509 weighing scale) were measured and women were randomized (first randomization) into a preconception intervention and control groups. All women were followed up till they became pregnant or 18 months from enrolment. If any woman did not become pregnant within 18 months from enrolment, the woman was excluded from the study. An ultrasound (GE ultrasound Voluson S8, PI Healthcare Inc., 23865 Via Del Rio, Yorba Linda CA 92887, USA) was done between 9–13 weeks to confirm pregnancy for women who reported pregnancy [2]. Within 14 weeks of gestation, eligible participants were rescreened and written informed consent (second consent) obtained again for further participation in the study and randomized again (second randomization) to either receive interventions or routine care in control group.

Four intervention groups were a) preconception, pregnancy and childhood, b) preconception, c) pregnancy and early childhood, and d) routine care. Details regarding interventions and interventions delivery have been discussed previously [2]. Briefly, interventions were given during pre- and peri-conception on health, nutrition, psychosocial care and support, and water, sanitation and hygiene. Pregnant women in intervention group with BMI between 16 kg/m2 and 18.5 kg/m2 were provided locally made snacks containing 500 kcal energy and 6–10 g protein per packet, whereas double amount was given to the women with BMI < 16 kg/m2. As a source of high quality protein, all women with BMI < 21 kg/m2 were supplemented one egg or 180 ml milk (70 kcal energy and 6 g protein) six days a week. All pregnant women were given one recommended daily allowance of micronutrients supplement daily during the pregnancy period. On the other hand, pregnant women in control group were advised to seek routine care from government sources or private health providers. In intervention group, study team visited participants’ home weekly to reinforce interventions, replenish supplies and record compliance. During pregnancy, weight was assessed monthly at home or at the study clinic until 32 weeks, biweekly until 36 weeks and weekly until delivery to monitor GWG. A study team trained in anthropometry measured infant weight and length <14 days of birth. Anthropometry of 52% neonates was measured within 72 hours of birth and 93% of infants within 7 days of life.

The family wealth index was calculated for each participant by performing a principal component analysis based on all 33 assets owned by the household as done in national surveys [18]. The total scores were used to divide the population into five equal wealth quintiles: the poorest, very poor, poor, less poor and least poor.

Enrolment of the subjects in the current study

Women from the previous study [2] who became pregnant within 18 months of enrolment were included in the present study. Early pregnancy BMI was calculated and women were classified as underweight, normal weight, overweight or obese. Eligible women were then randomised to receive either the intervention or routine antenatal care.

Variables

Definition of primary exposure variables.

Maternal early pregnancy BMI and GWG were exposure variables. BMI at enrolment (<14 weeks of gestation) was calculated using this formula; weight (kg) divided by height (m) square. BMI was categorized to define underweight (BMI < 18.5 kg/m2), normal (BMI 18.5– < 25 kg/m2) and overweight or obese (BMI ≥ 25 kg/m2). GWG at different time points was calculated in the following way. Total GWG (kg) from enrolment to last visit of before delivery: the weight recorded at enrolment was subtracted from the last recorded weight before delivery. GWG between enrolment and 26 weeks: the weight measured at enrolment was subtracted from weight measured at 26 weeks. Weight gain from 27 weeks to last visit of before delivery: the weight recorded at 27 weeks was subtracted from the last recorded weight before delivery. GWG was categorized in to inadequate, adequate and excessive GWG using the IOM guideline [17] and calculation was reported elsewhere [16]. Inadequate GWG: < 0.44 kg/week for BMI < 18.5 kg/m2, < 0.35 kg/week for BMI 18.5–24.99 kg/m2, < 0.23 kg/week for BMI 25.0–29.99 kg/m2, and <0.17 kg/week for BMI ≥ 30 kg/m2. Adequate GWG: 0.44 to 0.58 kg/week for BMI < 18.5 kg/m2, 0.35 to 0.50 kg/week for BMI 18.5–24.99 kg/m2, 0.23 to 0.33 kg/week for BMI 25.0–29.99 kg/m2, and 0.17 to 0.27 kg/week for BMI ≥ 30 kg/m2. Excessive GWG: > 0.58 kg/week for BMI < 18.5 kg/m2, > 0.50 kg/week for BMI 18.5–24.99 kg/m2, > 0.33 kg/week for BMI 25.0–29.99 kg/m2, and >0.27 kg/week for BMI ≥ 30 kg/m2. A nine groups categorical variable was generated by combining early pregnancy BMI and GWG categories, and normal weight with AGWG was used as the comparator. Also a single variable of four intervention groups was created.

Definition of outcome variables.

Continuous outcome variables were weight and length. Categorical outcome variables were term SGA (<10th percentile of a INTERGROWTH-21 standards by gestational age and sex) [19], preterm (<37 weeks of gestational age), stunting and wasting. Stunting and wasting were defined as length-for-age and weight-for-length z scores < -2SD respectively according to World Health Organization growth standards [20]. Weight less than 2500 g measured <14 days of birth was considered to define LBW. Gestational age in weeks at birth was calculated by estimating the duration in weeks from the date of the ultrasound examination to the date of birth, and adding this to the gestational age in weeks at the time of the ultrasound, as determined using the INTERGROWTH-21 standards [21].

Inclusion criteria.

The following inclusion criteria were set for this analysis: antenatal women with gestational age < 14 weeks at enrolment, singleton pregnancy and neonates delivered by these women within <14 days of birth.

Exclusion criteria.

Women living in temporary housing and those moving away from study area were excluded.

Power calculation.

The available sample size had at least 80% power to detect a RR of 1.4 between BMI 18.5 and 24.99 kg/m2 and IGWG and adverse pregnancy outcomes, assuming an adverse birth outcome prevalence between 7% and 35% among women with BMI 18.5 and 24.99 kg/m2 and AGWG with 5% significance level.

Statistical analyses

Continuous sociodemographic variables were reported as mean (SD) given their normal distribution, while categorical variables were summarized as frequency (%). Based on previous evidences, a Directed Acyclic Graph (http://www.dagitty.net/) was developed to show the potential confounders by visually representing the casual relationships between variables in the study (S1 Fig). We included variables that changed risk ratio (RR) and β-coefficient of the outcome variables by 5%–10% in the univariable models included in the multivariate models; these were maternal age, maternal education, intervention and family wealth quintile. For binary outcomes, including term SGA, LBW, preterm birth, stunting, and wasting, we fitted generalized linear models (GLMs) with a log link to estimate risk ratios (RRs) and 95% confidence intervals (CIs). Models of the binomial family were applied where possible, with robust Poisson models used in instances of non-convergence [22]. For continuous outcomes such as infant birthweight and length, we used GLMs from the Gaussian family with an identity link to estimate mean differences and 95% CIs. Each analysis followed a two-step approach: first presenting unadjusted associations and subsequently adjusting for pre-specified covariates, with both sets of estimates displayed in the tables. Results for total GWG were summarized in forest plots, while trimester-specific GWG findings were presented in tabular form. To assess potential effect modification, we generated regression lines with 95% CIs illustrating the interaction between early-pregnancy BMI and GWG. In addition, we calculated and depicted the prevalence of term SGA, LBW, stunting, and preterm birth across categories of maternal BMI and GWG using bar diagrams. All analyses were performed using Stata version 14 (StataCorp, College Station, TX, USA). Statistical significance was defined as p < 0.05, with 95%CI.

Results

At second randomization, 4921 pregnant women whose weight and height were measured during prepregnancy were enrolled in this study. Based on the inclusion and exclusion criteria, baseline information was available for 3855 women, and anthropometric measurements were collected for 3695 singleton infants (<14 days of birth), who were included in the analysis (Fig 1). [Fig 1. Flow diagram of enrolment, randomization, followup and outcomes].

Fig 1. GA, gestational age.

Fig 1

Sociodemographic characteristics of the participated women are presented in Table 1.

Table 1. Sociodemographic characteristics of the study participants at enrolmenta.

Characteristics n = 3855
Family having below poverty line card, n (%) 153 (4·0)
Family covered by health insurance scheme, n (%) 418 (10·8)
Age at enrolment (years), mean (SD) 23·8 (3·0)
Weight at enrolment (kg), mean (SD) 52.3 (10.0)
Height at enrolment (cm), mean (SD) 152·4 (5·6)
Early pregnancy body index (kg/m2), n (%)
  Underweight (<18·5 586 (15·2)
  Normal weight (18·5 – 24·9) 2311 (60·0)
  Overweight (25 – 29·9) 792 (20·5)
  Obese (≥30) 166 (4·3)
Gestational age at enrolment (weeks), mean (SD) 10·9 (1·4)
Gestational age at delivery (weeks), mean (SD) 38·7 (1·5)
Total gestational weight gain (kg), mean (SD) 8.2 (3.6)
Parity, n (%)
  0 1633 (42·4)
  1 2222 (57·6)
Year of schooling, mean (SD) 10·5 (4·1)
Women occupation, housewife, n (%) 3668 (95·2)
Family type (joint), n (%) 2172 (56·3)
Wealth quintile, n (%)
  Poorest

  Very poor
593 (15·4)

767 (19·9)
  Poor 818 (21·2)
  Less poor 875 (22·7)
  Least poor 802 (20·8)

aData presented as mean (SD) or frequency (%).

Association of early pregnancy BMI and GWG with infant weight and length

Linear regression analysis was done to find the associations between early pregnancy BMI, GWG, and continuous outcomes (infant weight in g and length in cm) and unadjusted and adjusted β-values are shown in S1 Table and S2 Table. For total GWG, IGWG among normal BMI women (adjusted β -126·62; 95%CI -163·78– -89·46) and IGWG among underweight women (adjusted β -239·12; 95%CI -289·53– -188·72) were associated with LBW compared to normal BMI women with AGWG. Conversely, EGWG among normal BMI (adjusted β 92·22; 95%CI 40·39–144·04) and overweight or obese women (adjusted β 116·26; 95%CI 65·38–167·14) was associated with higher birth weight. Similar trends were observed for length, with stronger associations in the second trimester compared to the third trimester.

Distribution of adverse birth outcomes by early pregnancy BMI and GWG

The overall prevalence of term SGA (62.4%; 95%CI 57.1–67.5), LBW (47.3%; 95%CI 42.0–52.7), stunting (37.3%; 95%CI 32.3–42.6) and preterm (10.1%; 95%CI 7.3–13.8) among infants of underweight women (BMI < 18·5 kg/m²) with IGWG were higher compared to other groups (S2 Fig). Same pattern was observed for trimester-specific GWG (S3 and S4 Figs).

Association between early pregnancy BMI, GWG, and term SGA

For total GWG, after adjusting for confounders, IGWG among normal BMI women (aRR 1.36; 95%CI 1.21–1.53) and IGWG among underweight women (aRR 1.65; 95%CI 1.44–1.89) were found to be higher risk of term SGA, and overweight or obese with EGWG (aRR 0.56; 95%CI 0.43–0.72) was associated with reduced the risk of SGA (Fig 2A). In the second trimester, IGWG among underweight women (aRR 1.44; 95%CI 1.27–1.64) was found to be a higher risk. In contrast, normal BMI women with EGWG (aRR 0.75; 95%CI 0.62–0.91), overweight or obese with AGWG (aRR 0.55; 95%CI 0.41–0.73), overweight or obese with IGWG (aRR 0.84; 95%CI 0.71–0.99) and overweight or obese with EGWG (aRR 0.50; 95%CI 0.39–0.65) were associated with reduced the risk of SGA. Similar trends were observed in the third trimester (Table 2). [Fig 2A. Associations of early pregnancy BMI and total GWG with term SGA].

Fig 2. GLMs of the Binomial or Poisson family with a log-link function was used to calculate RR after adjusting for maternal age, maternal education, family wealth quintile and intervention.

Fig 2

Early pregnancy nutritional status was defined using the following cut-off pints: underweight (BMI < 18.5), normal weight (BMI 18.5–24.9), and overweight or obese (BMI ≥ 25). GWG was categorized as inadequate, adequate and excessive GWG according to the IOM cut-off points. Normal weight with AGWG were used as comparator to calculated RR and presented on X-axis with 95%CI. AGWG, adequate gestational weight gain; BMI, body mass index; CI, confidence intervals; EGWG, excessive gestational weight gain; GLM, generalized linear model; GWG, gestational weight gain; IGWG, inadequate gestational weight gain; IOM, Institute of medicine; LBW, low birth weight; RR, risk ratio; SGA, small for gestational age.

Table 2. Association between early pregnancy BMI and GWG with SGA and LBW during second and third trimesters.

Variables SGA (RR 95% CI) LBW (RR 95% CI)
Unadjusted P value Adjusteda P value Unadjusted P value Adjusteda P value
GWG from enrolment to 26 weeks of gestation (n = 3502)
BMI 18·5 – < 25·0 and AGWG Ref Ref Ref Ref
BMI 18·5 – < 25·0 and IGWG 1·13(1.01–1.27) 0.034 1.11(0.99–1.24) 0.076 1·23(1·05–1·43) 0.010 1·21(1·03–1·41) 0.017
BMI 18·5 – < 25·0 and EGWG 0·74(0·61–0·90) 0.003 0.75(0.62–0.91) 0.004 0·73(0·56–0·95) 0.019 0·73(0·56–0·95) 0.021
BMI < 18·5 and AGWG 1·24(1·02–1·50) 0.028 1.20(0.99–1.45) 0.069 1·23(0·93–1·62) 0.146 1·20(0·91–1·58) 0.198
BMI < 18·5 and IGWG 1·50(1·32–1·71) 0.000 1.44(1.27–1.64) 0.000 1·93(1·63–2·29) 0.000 1·87(1·57–2·22) 0.000
BMI < 18·5 and EGWG 0·93(0·64–1·34) 0.686 0.91(0.63–1.31) 0.616 0·76(0·43–1·34) 0.340 0·75(0·43–1·34) 0.333
BMI ≥ 25·0 and AGWG 0·54(0·41, 0·72) 0.000 0.55(0.41–0.73) 0.000 0·66(0·47–0·92) 0.014 0·66(0·47–0·93) 0.017
BMI ≥ 25·0 and IGWG 0·84(0·71–0·99) 0.043 0.84(0.71–0.99) 0.046 1·03(0·83–1·27) 0.820 1·02(0·82–1·26) 0.861
BMI ≥ 25·0 and EGWG 0·49(0·38–0·63) 0.000 0.50(0.39–0.65) 0.000 0·74(0·57–0·98) 0.033 0·76(0·58–1·00) 0.051
GWG from 27 weeks to the last visit of before delivery (n = 2949)
BMI 18·5 – < 25·0 and AGWG Ref Ref Ref Ref
BMI 18·5 – < 25·0 and IGWG 1·22(1·07–1·40) 0.004 1.22(1.07–1.40) 0.003 1·38(1·13–1·68) 0.002 1.38(1.13–1.68) 0.002
BMI 18·5 – < 25·0 and EGWG 0·98(0·84–1·15) 0.806 0.98(0.84–1.45) 0.824 1·05(0·83–1·32) 0.685 1.05(0.83–1.32) 0.684
BMI < 18·5 and AGWG 1·13(0·86–1·48) 0.378 1.10(0.84–1.44) 0.495 1·62(1·16–2·26) 0.005 1.60(1.14–2.24) 0.006
BMI < 18·5 and IGWG 1·64(1·42–1·90) 0.000 1.58(1.37–1.83) 0.000 2·17(1·76–2·67) 0.000 2.13(1.72–2.63) 0.000
BMI < 18·5 and EGWG 1·15(0·83–1·60) 0.399 1.11(0.80–1.54) 0.537 1·15(0·70–1·90) 0.579 1.13(0.68–1.86) 0.643
BMI ≥ 25·0 and AGWG 0·76(0·57–1·01) 0.062 0.79(0.59–1.05) 0.110 0·86(0·58–1·28) 0.462 0.88(0.59–1.30) 0.511
BMI ≥ 25·0 and IGWG 0·73(0·55–0·97) 0.030 0.75(0.57–0.99) 0.049 0·90(0·62–1·29) 0.559 0.91(0.63–1.31) 0.604
BMI ≥ 25·0 and EGWG 0·62(0·50–0·76) 0.000 0.64(0.52–0.79) 0.000 0·85(0·66–1·11) 0.231 0.86(0.67–1.12) 0.276

Values are calculated using GLMs of the Binomial or Poisson family with a log-link function, compared with reference value, normal BMI with AGWG, and presented as RR and 95% confidence intervals, and p value.

AGWG, adequate gestational weight gain; BMI, body mass index; CI, confidence intervals; EGWG, excessive gestational weight gain; IGWG, inadequate gestational weight gain; LBW, low birth weight; RR, risk ratio; SGA, small for gestational age.

aAdjusted variables: Maternal age, maternal education, family wealth quintile and intervention.

Association between early pregnancy BMI, GWG, and LBW

Adjusted associations between early pregnancy BMI and total GWG with LBW is shown in Fig 2B. While, unadjusted and adjusted associations in the second and third trimesters are shown in Table 2. Inadequate GWG among normal BMI women (aRR 1·43; 95%CI 1·21–1·70) and IGWG among underweight women (aRR 2·09; 95%CI 1·74–2·52) were associated with an increased risk of LBW, compared to normal BMI women with AGWG. Conversely,

EGWG among overweight or obese women was associated with a reduced risk of LBW (aRR 0·73; 95%CI 0·54–0·98) (Fig 2B). Similar trends were observed for increasing the risk in the second trimester. Though, normal BMI with EGWG (aRR 0.73; 95%CI 0.56–0.95) and AGWG among overweight or obese women (aRR 0·66; 95%CI 0·47–0·93) reduced the risk of LBW, but no protective effect of AGWG or EGWG was observed in the third trimester (Table 2). [Fig 2B. Associations of early pregnancy BMI and total GWG with LBW].

Association between early pregnancy BMI, GWG, and preterm

After adjusting for maternal age, maternal education, family wealth quintile, and intervention effect, RRs for total GWG in preterm birth are shown in Fig 2C. EGWG among normal BMI women was associated with a reduced risk of preterm birth (aRR 0·44; 95%CI 0·22–0·88), compared to normal BMI women with AGWG. In the second trimester, normal BMI women with IGWG (aRR 1.38; 95%CI 1.03–1.86), underweight women with IGWG (aRR 1.65; 95%CI 1.15–2.37), overweight or obese women with IGWG (aRR 1.48; 95%CI 1.03–2.12), and overweight or obese women with EGWG (aRR 1.64; 95%CI 1.12–2.42) increased the risk of preterm, compared to normal BMI women with AGWG (Table 3). Similar pattern was observed in the third trimester. However, degree of risk was higher the third trimester compared to the second trimester (Table 3). [Fig 2C. Associations of early pregnancy BMI and total GWG with preterm].

Table 3. Association between early pregnancy BMI and GWG with preterm and stunting during second and third trimesters.

Variables Preterm (RR 95% CI) Stunting (RR 95% CI)
Unadjusted P value Adjusteda P value Unadjusted P value Adjusteda P value
GWG from enrolment to 26 weeks of gestation (n = 3502)
BMI 18·5 – < 25·0 and AGWG Ref Ref Ref Ref
BMI 18·5 – < 25·0 and IGWG 1·43(1·06–1·91) 0.017 1·38(1·03–1·86) 0.030 1.29(1.10–1.52) 0.003 1.29(1.10–1.52) 0.002
BMI 18·5 – < 25·0 and EGWG 0·74(0·46–1·21) 0.236 0·75(0·46–1·22) 0.250 0.71(0.54–0.94) 0.019 0.71(0.54–0.94) 0.017
BMI < 18·5 and AGWG 1·24(0·73–2·13) 0.430 1·21(0·70–2·07) 0.497 0.96(0.69–1.34) 0.812 0.93(0.66–1.31) 0.692
BMI < 18·5 and IGWG 1·71(1·19–2·45) 0.003 1·65(1·15–2·37) 0.006 1.86(1.55–2.23) 0.000 1.82(1.51–2.18) 0.000
BMI < 18·5 and EGWG 0·90(0·34–2·37) 0.828 0·91(0·35–2·42) 0.856 0.73(0.40–1.35) 0.316 0.73(0.40–1.33) 0.300
BMI ≥ 25·0 and AGWG 1·42(0·90–2·22) 0.129 1·39(0·88–2·28) 0.156 0.79(0.57–1.09) 0.151 0.82(0.60–1.13) 0.229
BMI ≥ 25·0 and IGWG 1·52(1·06–2·17) 0.022 1.48(1·03–2·12) 0.035 1.01(0.81–1.27) 0.905 1.04(0.83–1.31) 0.714
BMI ≥ 25·0 and EGWG 1·63(1·12–2·38) 0.011 1·64(1·12–2·42) 0.011 0.84(0.64–1.10) 0.214 0.87(0.66–1.15) 0.331
GWG from 27 weeks to the last visit of before delivery (n = 2949)
BMI 18·5 – < 25·0 and AGWG Ref Ref Ref Ref
BMI 18·5 – < 25·0 and IGWG 2·37(1·48–3·80) 0.000 2·40(1·50–3·84) 0.000 1.31(1.07–1.60) 0.008 1.34(1.10–1.64) 0.004
BMI 18·5 – < 25·0 and EGWG 1·24(0·71–2·16) 0.458 1·23(0·70–2·15) 0.468 0.96(0.76–1.21) 0.737 0.95(0.75–1.20) 0.663
BMI < 18·5 and AGWG 2·52(1·19–5·32) 0.015 2·53(1·20–5·36) 0.015 1.28(0.87–1.87) 0.196 1.27(0.87–1.86) 0.217
BMI < 18·5 and IGWG 2·43(1·40–4·21) 0.002 2·46(1·41–4·28) 0.002 1.68(1.34–2.12) 0.000 1.67(1.32–2.10) 0.000
BMI < 18·5 and EGWG 1·38(0·43–4·47) 0.591 1·36(0·42–4·43) 0.606 1.49(0.98–2.28) 0.065 1.43(0.94–2.19) 0.098
BMI ≥ 25·0 and AGWG 2·15(1·09–4·26) 0.028 2·15(1·08–4·27) 0.029 0.99(0.69–1.43) 0.968 1.03(0.72–1.48) 0.879
BMI ≥ 25·0 and IGWG 0·96(0·40–2·34) 0.933 0·98(0·40–2·43) 0.960 0.77(0.52–1.14) 0.185 0.81(0.54–1.20) 0.288
BMI ≥ 25·0 and EGWG 1·96(1·16–3·32) 0.012 1·95(1·15–3·32) 0.013 0.81(0.63–1.06) 0.123 0.83(0.64–1.09) 0.179

Values are calculated using GLMs of the Binomial or Poisson family with a log-link function, compared with reference value, normal BMI with AGWG, and presented as RR and 95% confidence intervals, and p value.

AGWG, adequate gestational weight gain; BMI, body mass index; CI, confidence intervals; EGWG, excessive gestational weight gain; IGWG, inadequate gestational weight gain; RR, risk ratio.

aAdjusted variables: Maternal age, maternal education, family wealth quintile and intervention.

Association between early pregnancy BMI, GWG and stunting and wasting

Fig 3A and 3B show the adjusted associations of early pregnancy BMI and total GWG with stunting and wasting. Total IGWG among normal BMI women was associated with increased risk of stunting (aRR 1·44; 95%CI 1·21–1·70), and wasting (aRR 1·36; 95%CI 1·09–1·71). Among underweight women with IGWG, the risks of stunting (aRR 1·78; 95%CI 1·46–2·17), and wasting (aRR 1·58; 95%CI 1·20–2·10) were significantly higher. However, EGWG among overweight or obese women was protective effect for wasting (aRR 0·58; 95%CI 0·38–0·87). No significant association was found of overweight or obese with EGWG

Fig 3. GLMs of the Binomial or Poisson family with a log-link function was used to calculate RR after adjusting for maternal age, maternal education, family wealth quintile, and intervention effect.

Fig 3

Early pregnancy nutritional status was defined using the following cut-off pints: underweight (BMI < 18.5), normal weight (BMI 18.5–24.9), and overweight or obese (BMI ≥ 25). GWG was categorized as inadequate, adequate and excessive GWG according to the IOM cut-off points. Normal weight with AGWG were used as comparator to calculated RR and presented on X-axis with 95%CI. AGWG, adequate gestational weight gain; BMI, body mass index; CI, confidence intervals; EGWG, excessive gestational weight gain; GLM, generalized linear model; GWG, gestational weight gain; IGWG, inadequate gestational weight gain; IOM, Institute of medicine; RR, risk ratio.

with stunting (Fig 3A). Similar patterns were observed for trimester-specific GWG among BMI category, though associations were stronger in the third trimester compared to the second trimester (Tables 3 and 4). [Fig 3A. Associations of early pregnancy BMI and total GWG with stunting; Fig 3B. Associations of early pregnancy BMI and total GWG with wasting]

Table 4. Association between early pregnancy BMI and GWG with wasting during second and third trimesters.

Variables Wasting (RR 95% CI)
Unadjusted P value Adjusteda P value
GWG from enrolment to 26 weeks of gestation (n = 3502)
BMI 18·5 – < 25·0 and AGWG Ref Ref
BMI 18·5 – < 25·0 and IGWG 1·11(0·89–1·38) 0.354 1.05(0.84–1.31) 0.660
BMI 18·5 – < 25·0 and EGWG 0·73(0·51–1·03) 0.077 0.74(0.52–1.05) 0.089
BMI < 18·5 and AGWG 1·26(0·86–1·84) 0.245 1.20(0.82–1.77) 0.343
BMI < 18·5 and IGWG 1·25(0·93–1·67) 0.134 1.19(0.89–1.60) 0.234
BMI < 18·5 and EGWG 0·85(0·42–1·73) 0.657 0.85(0.42–1.72) 0.651
BMI ≥ 25·0 and AGWG 0·66(0·42–1·03) 0.067 0.64(0.41–1.00) 0.051
BMI ≥ 25·0 and IGWG 1·03(0·77–1·37) 0.850 0.97(0.73–1.30) 0.859
BMI ≥ 25·0 and EGWG 0·51(0·34–0·79) 0.002 0.52(0.34–0.80) 0.003
GWG from 27 weeks to the last visit of before delivery (n = 2976)
BMI 18·5 – < 25·0 and AGWG Ref Ref
BMI 18·5 – < 25·0 and IGWG 1·47(1·12–1·93) 0.005 1.43(1.09–1.88) 0.009
BMI 18·5 – < 25·0 and EGWG 1·14(0·84–1·55) 0.393 1.16(0.86–1.58) 0.331
BMI < 18·5 and AGWG 1·40(0·84–2·33) 0.197 1.37(0.83–2.28) 0.221
BMI < 18·5 and IGWG 1·52(1·08–2·13) 0.016 1.47(1.04–2.07) 0.029
BMI < 18·5 and EGWG 1·33(0·71–2·51) 0.375 1.35(0.71–2.55) 0.359
BMI ≥ 25·0 and AGWG 0·85(0·50–1·44) 0.552 0.85(0.50–1.44) 0.539
BMI ≥ 25·0 and IGWG 0·94(0·59–1·52) 0.814 0.92(0.57–1.49) 0.731
BMI ≥ 25·0 and EGWG 0·91(0·64–1·28) 0.574 0.91(0.65–1.29) 0.606

Values are calculated using GLMs of the Binomial or Poisson family with a log-link function, compared with reference value, normal BMI with AGWG, and presented as RR and 95% confidence intervals, and p value.

AGWG, adequate gestational weight gain; BMI, body mass index; CI, confidence intervals; EGWG, excessive gestational weight gain; IGWG, inadequate gestational weight gain; RR, risk ratio.

aAdjusted variables: Maternal age, maternal education, family wealth quintile and intervention.

Interaction between early pregnancy BMI and GWG

Early pregnancy BMI significantly influenced the relationship between total GWG and infant weight and length. Notable interactions were observed for infant weight (p = 0·008) (Fig 4A) and length (p = 0·036) (Fig 4B). The association between GWG (kg) per week and these outcomes was more pronounced among underweight women (BMI < 18·5 kg/m²) compared to overweight or obese women (BMI ≥ 25 kg/m²) respectively. [Fig 4A. Relationship between GWG during pregnancy and infant weight stratified by early pregnancy BMI; Fig 4B. Relationship between GWG during pregnancy and infant length stratified by early pregnancy BMI]

Fig 4. The solid line indicates underweight (BMI < 18·5 kg/m2), the dash line shows normal weight (BMI 18·5– < 25 kg/m2) and the long dash dot line indicates overweight or obese (BMI ≥ 25 kg/m2).

Fig 4

The bands represent 95% CIs from the linear regression model. BMI, body mass index; CI, confidence interval; GWG, gestational weight gain.

Discussion

Approximately 15% of women in the study were underweight, while 25% were overweight or obese. Among the participants, 10% were underweight with IGWG, 3.4% were underweight with AGWG, and 21.8% had a normal BMI with AGWG. The prevalence of term SGA (62.4%), LBW (47.3%), stunting (37.3%), and preterm birth (10%) were higher among underweight women with IGWG compared to other groups. The risk of LBW was two times, term SGA 1.65 times, stunting 1.78 times, and wasting 1.58 times higher among underweight women with IGWG compared to women with normal BMI and AGWG. Conversely, among overweight or obese women with EGWG, the risk of LBW was reduced by 27% and followed by SGA 44%, and wasting 42% compared to women with normal BMI and AGWG.

Research from other low- and middle-income countries [23] has reported that EGWG among women with higher early pregnancy BMI is related with increased birth weight, while IGWG is associated with LBW. Similarly, studies from sub-Saharan Africa have reported that IGWG increased and EGWG reduced the risk of LBW. These findings highlight the importance of AGWG to reduce the risk of LBW, particularly among underweight women [24,25].

Underweight women with IGWG were more likely to deliver preterm birth, with a higher risk occurring during the third trimester compared to the second trimester. The likelihood of having preterm birth was different across different BMI categories and GWG levels. A greater risk was found among women who were already overweight or obese and also gained an excessive weight during pregnancy. These findings are consistent with study from other countries [2628]. They have shown a higher chance of preterm birth in pregnant women with EGWG, specially during the third trimester. In the analysis, a positive association was found between SGA and IGWG among underweight and normal weight women, while EGWG among overweight or obese women reduced the SGA. The degree of association varied by trimester, with stronger effects observed in the second trimester. These findings are consistent with previous studies, including a meta-analysis by Goldstein et al. (2018) [13]. They concluded that IGWG is a risk of SGA, particularly among underweight women. Another study has reported the similar finding that IGWG increases and AGWG in the second trimester reduces the risk of SGA [26]. These results underscore the importance of AGWG particularly during the second trimester, to reduce the risk of SGA. The combined effects of early pregnancy BMI and GWG were also evident for stunting and wasting. Risks of these outcomes increased among underweight and normal weight women with IGWG, and stronger effects observed among underweight women. Limited studies have explored these associations, findings from rural Malawi and Vietnam supported the role of AGWG in reducing stunting [24,29]. These results highlight the need for targeted interventions to improve GWG among underweight women to optimize infant growth outcomes.

A systematic review conducted in 25 LMICs reported that 54% and 22% of women had inadequate and excessive GWG, respectively [30]. Although the prevalence of IGWG in our study was lower than that reported in the review, the proportion with EGWG was comparable. The review highlighted nutritional, behavioural, and clinical determinants as key drivers of IGWG. Compared with another study from India [31], our cohort had a higher prevalence of both IGWG and EGWG, and a lower prevalence of AGWG. That study reported a strong association between lower energy and fat intake and IGWG, underscoring the importance of dietary quality and quantity during pregnancy.

In our setting, pregnant women generally consumed less food than the amounts recommended by the Indian Council of Medical Research, which may be related to pregnancy-related symptoms such as loss of appetite, abdominal fullness, and bloating [31]. In addition, women may have eaten smaller portions and a less diverse diet because of household dietary norms, gendered food allocation, and constrained food availability. Together, these findings suggest that both inadequate and excessive GWG in this population are shaped by a complex interplay of individual symptoms, nutritional intake, and structural barriers to food access, and highlight the need for context-specific dietary counselling and social support interventions during pregnancy.

Several potential mechanisms may underlie these findings. Higher GWG is linked to increased maternal plasma volume expansion, greater fat deposition, and enhanced placental nutrient transfer, all of which support optimal fetal growth [32]. Conversely, IGWG can impair placental function and restrict fetal growth. Excessive GWG may expose the fetus to elevate levels of glucose and fatty acids, which can positively influence birth weight and other outcomes [33]. Inadequate GWG has also been associated with an increased risk of premature rupture of membranes, reproductive tract infections, and preterm birth. In contrast, EGWG is linked to conditions such as preeclampsia and edema, both of which are risk factors for preterm delivery [34,35]. The study also highlighted a high prevalence of underweight (15%) and anaemia (22%) among women, with underweight women having a 30% higher risk of anaemia. Both anaemia and undernutrition are well-established risk factors for intrauterine growth restriction [36]. Notably, underweight women (BMI < 18.5 kg/m²) with EGWG faced an increased risk of fetal growth restriction and adverse birth outcomes.

The study has some limitations. Maternal weight was not recorded at birth to calculate the total weight gain during entire pregnancy. Several potential confounders were not measured, such as physical activity, and dietary intake which could have provided a more comprehensive understanding of factors influencing GWG and pregnancy outcomes. Additionally, while we screened for clinical intermediaries such as gestational diabetes, pregnancy-induced hypertension, and anemia, these were excluded from the final multivariable models because their inclusion did not alter the risk ratios or β -coefficients of the primary outcomes by the pre-specified threshold of 5%–10%. While this parsimonious approach focuses on the most statistically influential predictors, we acknowledge that these clinical conditions remain biologically relevant. Their exclusion might limit our ability to explore specific pathological pathways, though it ensures the stability and interpretability of our primary associations. Lastly, infant anthropometric outcomes were assessed within <14 days of birth, which may have introduced some variability in measurements due to postnatal weight and length changes during this period.

This study has several notable strengths. The prospective cohort design, with multiple antenatal weight measurements, allowed for trimester-specific assessment of GWG, providing detailed insights into its impact on pregnancy outcomes. The large sample size, combined with the inclusion of a significant proportion of underweight women, enabled robust comparisons across BMI categories. Gestational age was precisely determined using high-resolution ultrasonography.

Conclusion

This study demonstrates that underweight women with inadequate gestational weight gain face the highest risk of adverse outcomes compared to normal BMI and adequate gestational weight gain.

Recommendation

Regular monitoring of gestational weight gain is essential, and timely energy and protein supplementation should be ensured for women who are underweight and/or experience inadequate weight gain during pregnancy.

Supporting information

S1 Table

Association between early pregnancy body mass index and gestational weight gain with infant weight across pregnancy. Values were calculated using GLMs of the Gaussian family with an identity-link function, compared with reference value, normal BMI with AGWG, and presented as β-coefficient and 95% CIs. AGWG, adequate gestational weight gain; BMI, body mass index; CI, confidence interval; EGWG, excessive gestational weight gain; GLM, generalized linear model; IGWG, inadequate gestational weight gain. 1Adjusted variables: maternal age, maternal education, family wealth quintile and intervention.

(DOCX)

pgph.0005932.s001.docx (19.6KB, docx)
S2 Table. Association between early pregnancy body mass index and gestational weight gain with infant length across pregnancy.

Values were calculated using GLMs of the Gaussian family with an identity-link function, compared with reference value, normal BMI with AGWG, and presented as β-coefficient and 95% CIs. AGWG, adequate gestational weight gain; BMI, body mass index; CI, confidence interval; EGWG, excessive gestational weight gain; GLM, generalized linear model; IGWG, inadequate gestational weight gain.1Adjusted variables: maternal age, maternal education, family wealth quintile and intervention.

(DOCX)

pgph.0005932.s002.docx (18.1KB, docx)
S1 Fig. Directed Acyclic Graph, to shows the exposure, outcomes, confounders and mediators variables.

Exposure: Gestational weight gain & early pregnancy BMI; Outcome: Adverse pregnancy outcomes; Confounders changed risk ratio: Maternal age, maternal education, family wealth quintile and intervention; Potential confounders did not change risk ratio: Family type, anthropometry measurement duration, religion and parity; Potential mediator: Anaemia; BMI, body mass index.

(TIF)

pgph.0005932.s003.tif (166.5KB, tif)
S2 Fig. Prevalence of small for gestational age, low birth weight, stunting and preterm by early pregnancy body mass index and total gestational weight gain.

AGWG, adequate gestational weight gain; BMI, body mass index; EGWG, excessive gestational weight gain; IGWG, inadequate gestational weight gain; LBW, low birth weight; SGA, small for gestational age.

(TIF)

pgph.0005932.s004.tif (271.4KB, tif)
S3 Fig. Prevalence of small for gestational age, low birth weight, stunting and preterm by early pregnancy body mass index and gestational weight gain (from enrolment to 26 weeks of gestation).

AGWG, adequate gestational weight gain; BMI, body mass index; EGWG, excessive gestational weight gain; IGWG, inadequate gestational weight gain; LBW, low birth weight; SGA, small for gestational age.

(TIF)

pgph.0005932.s005.tif (303.2KB, tif)
S4 Fig. Prevalence of small for gestational age, low birth weight, stunting and preterm by early pregnancy body mass index and gestational weight gain (from 27 weeks of gestation to last visit of before delivery). legend.

AGWG, adequate gestational weight gain; BMI, body mass index; EGWG, excessive gestational weight gain; IGWG, inadequate gestational weight gain; LBW, low birth weight; SGA, small for gestational age.

(TIF)

pgph.0005932.s006.tif (285.4KB, tif)

Acknowledgments

We express our sincere gratitude to the participants and their families who participated in this study. We would also like to thank the data collection team for their contribution, and data management team for their digital data collection form development and data quality control.

Data Availability

Please find the dataset DOI: 10.5061/dryad.6t1g1jxbs.

Funding Statement

The study was funded by Biotechnology Industry Research Assistance Council (BIRAC) of the Department of Biotechnology, Government of India (GCI-ACT ref No BIRAC/GCI/0085/03/14-ACT to NB) and by the Bill & Melinda Gates Foundation, USA (grant ID OPP1191052 to NB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Lee AC, Kozuki N, Cousens S, Stevens GA, Blencowe H, Silveira MF, et al. Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH- 21(st) standard: Analysis of CHERG datasets. BMJ. 2017;358:j3677 10.1136/bmj.j3677 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Taneja S, Chowdhury R, Dhabhai N, Upadhyay RP, Mazumder S, Sharma S, et al. Impact of a package of health, nutrition, psychosocial support, and WaSH interventions delivered during preconception, pregnancy, and early childhood periods on birth outcomes and on linear growth at 24 months of age: factorial, individually randomised controlled trial. BMJ. 2022;379:e072046. doi: 10.1136/bmj-2022-072046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Jana A, Dey D, Ghosh R. Contribution of low birth weight to childhood undernutrition in India: evidence from the national family health survey 2019-2021. BMC Public Health. 2023;23(1):1336. doi: 10.1186/s12889-023-16160-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kerac M, James PT, McGrath M, Brennan E, Cole T, Opondo C, et al. Malnutrition in infants aged under 6 months: prevalence and anthropometric assessment - analysis of 56 low- and middle-income country DHS datasets. BMJ Glob Health. 2025;10(5):e016121. doi: 10.1136/bmjgh-2024-016121 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ray JG, Park AL, Fell DB. Mortality in Infants Affected by Preterm Birth and Severe Small-for-Gestational Age Birth Weight. Pediatrics. 2017;140(6):e20171881. doi: 10.1542/peds.2017-1881 [DOI] [PubMed] [Google Scholar]
  • 6.Jana A, Saha UR, Reshmi RS, Muhammad T. Relationship between low birth weight and infant mortality: evidence from National Family Health Survey 2019-21, India. Arch Public Health. 2023;81(1):28. doi: 10.1186/s13690-023-01037-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Sacchi C, Marino C, Nosarti C, Vieno A, Visentin S, Simonelli A. Association of Intrauterine Growth Restriction and Small for Gestational Age Status With Childhood Cognitive Outcomes: A Systematic Review and Meta-analysis. JAMA Pediatr. 2020;174(8):772–81. doi: 10.1001/jamapediatrics.2020.1097 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Perumal N, Manji KP, Darling AM, Kisenge RR, Kvestad I, Hysing M, et al. Gestational Age, Birth Weight, and Neurocognitive Development in Adolescents in Tanzania. J Pediatr. 2021;236:194-203.e6. doi: 10.1016/j.jpeds.2021.04.036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Miele MJ, Souza RT, Calderon IM, Feitosa FE, Leite DF, Rocha Filho EA, et al. Maternal Nutrition Status Associated with Pregnancy-Related Adverse Outcomes. Nutrients. 2021;13(7):2398. doi: 10.3390/nu13072398 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lin D, Fan D, Wu S, Chen G, Li P, Ma H, et al. The effect of gestational weight gain on perinatal outcomes among Chinese twin gestations based on Institute of Medicine guidelines. BMC Pregnancy Childbirth. 2019;19(1):262. doi: 10.1186/s12884-019-2411-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Li Y, Zhao Y, Wu Y, Luo G. A study on the correlation between pregnancy risk factors and birth outcomes. Sci Rep. 2025;15(1):30749. doi: 10.1038/s41598-025-16775-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Wu Y, Wan S, Gu S, Mou Z, Dong L, Luo Z, et al. Gestational weight gain and adverse pregnancy outcomes: a prospective cohort study. BMJ Open. 2020;10(9):e038187. doi: 10.1136/bmjopen-2020-038187 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Goldstein RF, Abell SK, Ranasinha S, Misso ML, Boyle JA, Harrison CL, et al. Gestational weight gain across continents and ethnicity: systematic review and meta-analysis of maternal and infant outcomes in more than one million women. BMC Med. 2018;16(1):153. doi: 10.1186/s12916-018-1128-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Jiang Y, Wang X, Wu L, Huang X, Cao X. Effects of Maternal Prepregnancy Nutritional Status on Pregnancy Outcomes. Emerg Med Int. 2025;2025:1502902. doi: 10.1155/emmi/1502902 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Young MF, Nguyen PH, Addo OY, Hao W, Nguyen H, Pham H, et al. The relative influence of maternal nutritional status before and during pregnancy on birth outcomes in Vietnam. Eur J Obstet Gynecol Reprod Biol. 2015;194:223–7. doi: 10.1016/j.ejogrb.2015.09.018 [DOI] [PubMed] [Google Scholar]
  • 16.Chowdhury R, ▪ N, Choudhary TS, Dhabhai N, Mittal P, Dewan R, et al. Gestational weight gain and pregnancy outcomes: Findings from North Indian pregnancy cohort. Maternal & Child Nutrition. 2021;18(1). doi: 10.1111/mcn.13238 [DOI] [Google Scholar]
  • 17.Institute of Medicine (IOM). Weight gain during pregnancy: Reexamining the guidelines. Institute of medicine (US) and National Reaearch Council (US) and committee to reexamine IOM Pregnancy weight guidelines. 2009. [Google Scholar]
  • 18.International Institute for Population Sciences (IIPS), Macro International. National Family Health Survey (NFHS-4), I. H., 2015–2016. 2016. http://rchiips.org/nfhs/NFHS-4Report.shtml [Google Scholar]
  • 19.Papageorghiou AT, Kennedy SH, Salomon LJ, Altman DG, Ohuma EO, Stones W, et al. The INTERGROWTH-21st fetal growth standards: toward the global integration of pregnancy and pediatric care. Am J Obstet Gynecol. 2018;218(2S):S630–40. doi: 10.1016/j.ajog.2018.01.011 [DOI] [PubMed] [Google Scholar]
  • 20.WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards based on length/height, weight and age. Acta Paediatr Suppl. 2006;450:76–85. doi: 10.1111/j.1651-2227.2006.tb02378.x [DOI] [PubMed] [Google Scholar]
  • 21.Papageorghiou AT, Kemp B, Stones W, Ohuma EO, Kennedy SH, Purwar M, et al. Ultrasound-based gestational-age estimation in late pregnancy. Ultrasound Obstet Gynecol. 2016;48(6):719–26. doi: 10.1002/uog.15894 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Talbot D, Mésidor M, Chiu Y, Simard M, Sirois C. An Alternative Perspective on the Robust Poisson Method for Estimating Risk or Prevalence Ratios. Epidemiology. 2023;34(1):1–7. doi: 10.1097/EDE.0000000000001544 [DOI] [PubMed] [Google Scholar]
  • 23.Bauserman MS, Bann CM, Hambidge KM, Garces AL, Figueroa L, Westcott JL, et al. Gestational weight gain in 4 low- and middle-income countries and associations with birth outcomes: a secondary analysis of the Women First Trial. Am J Clin Nutr. 2021;114(2):804–12. doi: 10.1093/ajcn/nqab086 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Gondwe A, Ashorn P, Ashorn U, Dewey KG, Maleta K, Nkhoma M, et al. Pre-pregnancy body mass index (BMI) and maternal gestational weight gain are positively associated with birth outcomes in rural Malawi. PLoS One. 2018;13(10):e0206035. doi: 10.1371/journal.pone.0206035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Nemomsa D, Mesfin F, Damena M, Asefa F. Early-pregnancy body mass index and gestational-weight gain are important maternal markers of low birth weight in Harar town, Eastern Ethiopia. East African J Health and Biomed Sci. 2018;2:1–9. [Google Scholar]
  • 26.Wei X, Shen S, Huang P, Xiao X, Lin S, Zhang L, et al. Gestational weight gain rates in the first and second trimesters are associated with small for gestational age among underweight women: a prospective birth cohort study. BMC Pregnancy Childbirth. 2022;22(1):106. doi: 10.1186/s12884-022-04433-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Wei X, Shen S, Huang P, Xiao X, Lin S, Zhang L, et al. Gestational weight gain rates in the first and second trimesters are associated with small for gestational age among underweight women: a prospective birth cohort study. BMC Pregnancy Childbirth. 2022;22(1):106. doi: 10.1186/s12884-022-04433-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Yang J, Wang M, Tobias DK, Rich-Edwards JW, Darling AM, Abioye AI, et al. Gestational weight gain during the second and third trimesters and adverse pregnancy outcomes, results from a prospective pregnancy cohort in urban Tanzania. Reprod Health. 2022;19(1):140. doi: 10.1186/s12978-022-01441-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Tran NT, Nguyen LT, Berde Y, Low YL, Tey SL, Huynh DTT. Maternal nutritional adequacy and gestational weight gain and their associations with birth outcomes among Vietnamese women. BMC Pregnancy Childbirth. 2019;19(1):468. doi: 10.1186/s12884-019-2643-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Darling AM, Wang D, Perumal N, Liu E, Wang M, Ahmed T, et al. Risk factors for inadequate and excessive gestational weight gain in 25 low- and middle-income countries: An individual-level participant meta-analysis. PLoS Med. 2023;20(7):e1004236. doi: 10.1371/journal.pmed.1004236 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Mishra KG, Bhatia V, Nayak R. Maternal Nutrition and Inadequate Gestational Weight Gain in Relation to Birth Weight: Results from a Prospective Cohort Study in India. Clin Nutr Res. 2020;9(3):213–22. doi: 10.7762/cnr.2020.9.3.213 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Toro-Ramos T, Sichieri R, Hoffman DJ. Maternal fat mass at mid-pregnancy and birth weight in Brazilian women. Ann Hum Biol. 2016;43(3):212–8. doi: 10.3109/03014460.2015.1032348 [DOI] [PubMed] [Google Scholar]
  • 33.Lyu Y, Cui M, Zhang L, Zheng G, Zuo H, Xiu Q, et al. Pre-pregnancy body mass index, gestational diabetes mellitus, and gestational weight gain: individual and combined effects on fetal growth. Front Public Health. 2024;12:1354355. doi: 10.3389/fpubh.2024.1354355 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Montvignier Monnet A, Savoy D, Préaubert L, Hoffmann P, Bétry C. In Underweight Women, Insufficient Gestational Weight Gain Is Associated with Adverse Obstetric Outcomes. Nutrients. 2022;15(1):57. doi: 10.3390/nu15010057 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.An H, Jin M, Li Z, Zhang L, Li H, Zhang Y, et al. Impact of gestational hypertension and pre-eclampsia on preterm birth in China: a large prospective cohort study. BMJ Open. 2022;12(9):e058068. doi: 10.1136/bmjopen-2021-058068 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Figueiredo ACMG, Gomes-Filho IS, Silva RB, Pereira PPS, Mata FAFD, Lyrio AO, et al. Maternal Anemia and Low Birth Weight: A Systematic Review and Meta-Analysis. Nutrients. 2018;10(5):601. doi: 10.3390/nu10050601 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0005932.r001

Decision Letter 0

Nicola Hawley

15 Dec 2025

PGPH-D-25-02926

Impact of early pregnancy body mass index and gestational weight gain on birth outcomes: Findings from a pregnancy cohort in South Delhi, India

PLOS Global Public Health

Dear Dr. Chowdhury,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 14 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Nicola Hawley

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. Please amend your detailed Financial Disclosure statement. This is published with the article. It must therefore be completed in full sentences and contain the exact wording you wish to be published.

1. Please clarify all sources of funding (financial or material support) for your study. List the grants (with grant number) or organizations (with url) that supported your study, including funding received from your institution.

2. State the initials, alongside each funding source, of each author to receive each grant.

3. State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

4. If any authors received a salary from any of your funders, please state which authors and which funders.

2. Please provide separate figure files in .tif or .eps format.

For more information about figure files please see our guidelines:

https://journals.plos.org/globalpublichealth/s/figures

https://journals.plos.org/globalpublichealth/s/figures#loc-file-requirements

3. Please insert an Ethics Statement at the beginning of your Methods section, under a subheading 'Ethics Statement'. It must include:

1) The name(s) of the Institutional Review Board(s) or Ethics Committee(s)

2) The approval number(s), or a statement that approval was granted by the named board(s)

3) (for human participants/donors) - A statement that formal consent was obtained (must state whether verbal/written) OR the reason consent was not obtained (e.g. anonymity). NOTE: If child participants, the statement must declare that formal consent was obtained from the parent/guardian.

4. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

As you will see from the reviews, both reviewers were enthusiastic about the manuscript but requested additional clarity in terms of methods and potential limitations. Please pay particular attention to making sure all of the possible limitations are described.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?-->?>

Reviewer #1: Yes

Reviewer #2: I don't know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: No

**********

Reviewer #1: The work is Excellence and the idea is novel However, the authors needs to address these minor comments. The authors need to review the abstract, methodology, ethical issues, discussion , conclusion and recommendation and references but add the limitation section which is not included in the manuscript.

Reviewer #2: This Study seems to be an extension of Previous published Study -WINGS.Data from that Study has been used and it has been declared by the Authors.Statistical Analyses has to be checked by Domain experts.Certain Tables and Figures mentioned in the text are not available for perusal.Few corrections in presentation and wordings are mentioned in my report which would be uploaded.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes: Jonhas Masatu Malija

Reviewer #2: Yes: DR.CHANDRAKALA MARAN

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

Attachment

Submitted filename: Reviewer COMMENTS for Manuscript ID PGPH-D-25-02926.pdf

pgph.0005932.s007.pdf (124.5KB, pdf)
Attachment

Submitted filename: Peer review of Article for PLOS.docx

pgph.0005932.s008.docx (14.9KB, docx)
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0005932.r003

Decision Letter 1

Nicola Hawley

13 Jan 2026

PGPH-D-25-02926R1

Impact of early pregnancy body mass index and gestational weight gain on birth outcomes: Findings from a pregnancy cohort in South Delhi, India

PLOS Global Public Health

Dear Dr. Chowdhury,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Thank you for the careful attention to the initial reviewer comments. You will see that one of the reviewers raised some additional points for your consideration. Of those comments, I would appreciate your attention to the final one, which raises an important point about potential confounders. Please could you add a comment about that to the discussion?

Please submit your revised manuscript by Feb 12 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Nicola Hawley

Academic Editor

PLOS Global Public Health

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

publication criteria?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?-->?>

Reviewer #1: Yes

Reviewer #2: I don't know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: The authors have addressed all comments related to ethical issues raised by reviewers. I don't have ongoing concern in my perspective.

Reviewer #2: Few corrections are to be made following which the Article can be accepted.I have attached the needed changes.

Thank you.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes: Jonhas Masatu Malija

Reviewer #2: Yes: Dr.Chandrakala Maran

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

Attachment

Submitted filename: CORRECTED REVIEW.docx

pgph.0005932.s010.docx (12.3KB, docx)
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0005932.r005

Decision Letter 2

Nicola Hawley

19 Jan 2026

Impact of early pregnancy body mass index and gestational weight gain on birth outcomes: Findings from a pregnancy cohort in South Delhi, India

PGPH-D-25-02926R2

Dear Dr. Chowdhury,

We are pleased to inform you that your manuscript 'Impact of early pregnancy body mass index and gestational weight gain on birth outcomes: Findings from a pregnancy cohort in South Delhi, India' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Nicola Hawley

Academic Editor

PLOS Global Public Health

***********************************************************

Reviewer Comments (if any, and for reference):

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table

    Association between early pregnancy body mass index and gestational weight gain with infant weight across pregnancy. Values were calculated using GLMs of the Gaussian family with an identity-link function, compared with reference value, normal BMI with AGWG, and presented as β-coefficient and 95% CIs. AGWG, adequate gestational weight gain; BMI, body mass index; CI, confidence interval; EGWG, excessive gestational weight gain; GLM, generalized linear model; IGWG, inadequate gestational weight gain. 1Adjusted variables: maternal age, maternal education, family wealth quintile and intervention.

    (DOCX)

    pgph.0005932.s001.docx (19.6KB, docx)
    S2 Table. Association between early pregnancy body mass index and gestational weight gain with infant length across pregnancy.

    Values were calculated using GLMs of the Gaussian family with an identity-link function, compared with reference value, normal BMI with AGWG, and presented as β-coefficient and 95% CIs. AGWG, adequate gestational weight gain; BMI, body mass index; CI, confidence interval; EGWG, excessive gestational weight gain; GLM, generalized linear model; IGWG, inadequate gestational weight gain.1Adjusted variables: maternal age, maternal education, family wealth quintile and intervention.

    (DOCX)

    pgph.0005932.s002.docx (18.1KB, docx)
    S1 Fig. Directed Acyclic Graph, to shows the exposure, outcomes, confounders and mediators variables.

    Exposure: Gestational weight gain & early pregnancy BMI; Outcome: Adverse pregnancy outcomes; Confounders changed risk ratio: Maternal age, maternal education, family wealth quintile and intervention; Potential confounders did not change risk ratio: Family type, anthropometry measurement duration, religion and parity; Potential mediator: Anaemia; BMI, body mass index.

    (TIF)

    pgph.0005932.s003.tif (166.5KB, tif)
    S2 Fig. Prevalence of small for gestational age, low birth weight, stunting and preterm by early pregnancy body mass index and total gestational weight gain.

    AGWG, adequate gestational weight gain; BMI, body mass index; EGWG, excessive gestational weight gain; IGWG, inadequate gestational weight gain; LBW, low birth weight; SGA, small for gestational age.

    (TIF)

    pgph.0005932.s004.tif (271.4KB, tif)
    S3 Fig. Prevalence of small for gestational age, low birth weight, stunting and preterm by early pregnancy body mass index and gestational weight gain (from enrolment to 26 weeks of gestation).

    AGWG, adequate gestational weight gain; BMI, body mass index; EGWG, excessive gestational weight gain; IGWG, inadequate gestational weight gain; LBW, low birth weight; SGA, small for gestational age.

    (TIF)

    pgph.0005932.s005.tif (303.2KB, tif)
    S4 Fig. Prevalence of small for gestational age, low birth weight, stunting and preterm by early pregnancy body mass index and gestational weight gain (from 27 weeks of gestation to last visit of before delivery). legend.

    AGWG, adequate gestational weight gain; BMI, body mass index; EGWG, excessive gestational weight gain; IGWG, inadequate gestational weight gain; LBW, low birth weight; SGA, small for gestational age.

    (TIF)

    pgph.0005932.s006.tif (285.4KB, tif)
    Attachment

    Submitted filename: Reviewer COMMENTS for Manuscript ID PGPH-D-25-02926.pdf

    pgph.0005932.s007.pdf (124.5KB, pdf)
    Attachment

    Submitted filename: Peer review of Article for PLOS.docx

    pgph.0005932.s008.docx (14.9KB, docx)
    Attachment

    Submitted filename: Response to reviewers_20.12.2025.docx

    pgph.0005932.s009.docx (47.4KB, docx)
    Attachment

    Submitted filename: CORRECTED REVIEW.docx

    pgph.0005932.s010.docx (12.3KB, docx)
    Attachment

    Submitted filename: Response to Reviewer_14.01.2026.docx

    pgph.0005932.s011.docx (18.4KB, docx)

    Data Availability Statement

    Please find the dataset DOI: 10.5061/dryad.6t1g1jxbs.


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES